Clinical Trial Update: Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating irinotecan plus capecitabine as first-line therapy in Asian patients with hepatocellular carcinoma has completed. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: COMPLETED